Skip to content

Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI (PRECISE)

Risk Factors,PREvention and outComes for Contrast-Induced Acute Kidney Injury in patientS undErgoing Percutaneous Coronary Intervention:a Single-center Cohort Study(PRECISE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07020130
Acronym
PRECISE
Enrollment
3030
Registered
2025-06-13
Start date
2012-01-01
Completion date
2018-12-31
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CIN

Brief summary

A prospective observational study included all patients undergoing percutaneous coronary intervention(PCI) in Fujian Provincial Hospital from January 1st 2012 to December 31st 2018. The aim was to determine the incidence,risk factors,prophylactic strategy and outcomes of CI-AKI in patients undergoing PCI.

Interventions

None listed

Sponsors

Kaiyang Lin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill patients undergoing PCI at ICU

Exclusion criteria

* pregnancy lactation end-stage renal disease (eGFR \<15 mL/min/1.73 m2) long-term dialysis treatment intravascular administration of contrast medium within the last 7 or 3 days postoperatively

Design outcomes

Primary

MeasureTime frameDescription
CI-AKI5 yearThis was due to acute kidney injury following the use of intravascular contrast media. Serum creatinine is the primary measuring modalities.
CKD5 yearChronic renal structural and functional disorders that occurred during follow-up after administration of intravascular contrast agents, estimated glomerular filtration rate (eGFR) as the primary measuring modalities.

Secondary

MeasureTime frameDescription
all-cause mortality5 yearDefined as deaths occurring during follow-up after discharge from EPCI, excluding force majeure factors such as natural disasters and car accidents,and the necessary information was gathered during follow-up.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026